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    Abstract 
Background: New guidelines in the treatment of acute ischemic stroke include timely 
recognition of stroke symptoms and evaluation for rapid treatment of stroke with IV t-PA 
administration and endovascular intervention.  
Methods:  The DNP student/project coordinator led a collaborative effort to integrate the 
updated AHA/ASA ischemic stroke guideline through revision of the current in-house stroke 
algorithm; facilitation of the implementation plan; and evaluation of the implementation plan.    
Evaluation: The DNP student/project coordinator suggested an evaluation of the practice change 
through monthly discussion of algorithm fall-outs at the Stroke Committee meetings at the 
hospital.   
Significance and Implications: Implementation of this project introduced a practice change in 
the clinical setting for patients who experience an in-hospital stroke.  Early consideration for 
treatment with endovascular intervention may allow for an increase in the number of patients 
who are eligible to receive ischemic stroke intervention, and may lead to an improvement in 
stroke treatment response time.   
 
Keywords: Mechanical thrombolysis, stroke, endovascular intervention, thrombectomy 
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Implementation of New Practice in the Treatment of Acute Ischemic Stroke 
Introduction 
Stroke is a devastating event caused by a lack of blood flow to the brain resulting from a 
vascular rupture or occlusion of a cerebral vessel.  Close to 800,000 strokes occur each year in 
the United States and it is currently the fourth leading cause of death. Approximately 4% to 17% 
of reported strokes occur in patients who are hospitalized for other illnesses (Cumbler, Zaemisch, 
Graves, Brega, & Jones, 2011).  Recent literature suggests that patients who experience a stroke 
while hospitalized for other diagnoses are not afforded the same level of care and adherence to 
the recommended stroke core measures as those who arrive through the emergency medical 
system (Cumbler et al., 2013).    
Due to the variability in stroke diagnosis and treatment, there is a need for quality 
improvement initiatives aimed to decrease variability within the in-hospital stroke alert process 
(Cumbler et al., 2011).  Doing so may result in significant improvements in the functional 
outcome of patient who experiences a stroke while hospitalized (Cumbler et al., 2011).  To 
improve upon the time of stroke recognition to computed tomography (CT) scan, and stroke alert 
to intervention, it is necessary to develop a standardized clinical process, or algorithm for  
frontline responders to follow for all incidents of suspected stroke (Cumbler et al., 2011). 
Although those who suffer an in-hospital stroke have an opportunity to receive the 
standard treatment of available care, the process may be complicated by the patient’s 
comorbidities and a delay in the recognition of stroke symptoms (Moradiya & Levine, 2013).  In 
addition to the increased risk of stroke under-recognition, patients experiencing in-hospital stroke  
have a higher incidence of medical and surgical co-morbidities that may influence eligibility to 
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receive intravenous tissue plasminogen activator (IV t-PA), making it vital to offer the option of 
endovascular intervention early in the process of stroke management (Cumbler et al., 2011).   
A recent study by Cumbler et al. (2014) demonstrated an opportunity to improve in-
hospital adherence to the established core measures for stroke.  Cumbler et al. (2014) performed 
a retrospective cohort study utilizing data from a national database to evaluate the quality of care 
for the in-hospital stroke population.  The results from 1280 sites for in-hospital stroke patients 
(N=21,349) demonstrated a need for quality improvement efforts for this population (Cumbler et 
al., 2014).  In particular, patients who experienced an in-hospital stroke had a higher level of 
presenting deficits (P<0.0001), received IV t-PA at a lower rate and at a delayed time 
(P<0.0001), and were left with greater disabilities at discharge (P<0.001).  The standard of care 
in the treatment of acute stroke must be employed at both the in-hospital and emergency 
department settings (Cumbler et al., 2014).  
The 2013 American Heart Association/American Stroke Association (AHA/ASA) 
Guideline recommend sole use of mechanical thrombectomy for ischemic stroke treatment for 
patients who are ineligible to receive IV t-PA (Stetka & Lutsep, 2013).  The 2015 AHA/ASA 
stroke guideline amended this recommendation by including the need to consider both 
endovascular intervention and IV t-PA simultaneously for the treatment of acute ischemic stroke 
as the new standard of care (Powers et al., 2015). 
Problem Statement 
The American Heart Association/American Stroke Association (AHA/ASA) published a 
focused guideline in 2015 updating the 2013 recommendations (Powers et al., 2015).  The 
updated 2015 ischemic stroke guideline resulted in a paradigm shift in the treatment of acute 
ischemic stroke, including the recommendation to consider endovascular intervention early in the 
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stroke treatment plan.  The revised guideline advises to avoid waiting for the patient’s response 
to intravenous tissue plasminogen activator (IV t-PA) before considering endovascular 
intervention, and to consider endovascular intervention even if IV t-PA is contraindicated.  The 
third recommendation for healthcare systems was to design and implement processes that result 
in rapid assessment and treatment of the acute ischemic stroke population (Powers et al., 2015). 
As a result of the updated guideline, a clinical practice gap in the treatment of acute 
ischemic stroke was identified in the DNP student/project coordinator’s hospital system.  The 
current in-patient stroke algorithm addresses sole administration of IV t-PA (Figure 1), but did 
not advocate for the concurrent assessment of both administration of IV t-pa and endovascular 
intervention eligibility.   
Aims and Objectives 
The aim of this project was to introduce and incorporate recommendations from the 2015 
AHA/ASA acute ischemic stroke guideline into clinical practice for treatment of in-house acute 
ischemic stroke through the development and implementation of a revised hospital-wide stroke 
algorithm.  Objectives included a collaborative assessment of the current in-house stroke alert 
algorithm.  The hospital’s initial in-house algorithm did not reflect the latest recommendations, 
including endovascular treatment consideration with concurrent administration of IV t-Pa.   
Revision of this in-house stroke algorithm was achieved through a collaborative approach 
involving the DNP student/project coordinator and key stakeholders from the neuroscience 
department at the institution.  The second project objective was to shepherd the revised algorithm 
through the hospital’s approval process.  To accomplish this objective, the revised in-house 
algorithm was presented for approval to the stroke committee by the DNP student/project 
coordinator and the chief of neurology.  Upon approval, the chief of neurology presented the 
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revised algorithm to the Pharmacy and Therapeutics (P&T) committee, and then to the Medical 
Executive committee.  The third objective was to incorporate the recommended changes into 
clinical practice by using project planning techniques and program evaluation strategies to ensure 
successful integration of the new algorithm into institutional stroke care processes. 
To accomplish these objectives, the doctoral student/project coordinator incorporated 
recommendations for successful practice guideline implementation outlined by Shiffman, 
Michel, Essaihi, and Thornquist (2004), including: 
 Selecting specific recommendations that were used to revise the in-house stroke algorithm.  
Selected recommendations involved the early pursuit of endovascular intervention for 
ischemic stroke treatment. 
 Operationalized guideline recommendations through the revision of the current in-house 
stroke algorithm in collaboration with key members of the neuroscience inter-professional 
team members.  
 Presented recommended revisions to the algorithm to the chief of neurology for approval 
through the established health system committee structure. 
 Guided the implementation planning process for the revised algorithm with the endorsement 
of the stroke committee 
 Consulted with the stroke committee to perform a SWOT analysis to plan for implementation 
of quality improvement project. 
 Used established project management strategies to outline steps and timeline for 
implementation. 
 Selected strategies to assure attendance at inter-professional meetings arranged to present the 
revised algorithm to all clinical disciplines, allowing time for discussion and questions. 
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 Evaluated effectiveness of the implementation process by ongoing review of the process at 
the monthly stroke committee meetings. 
 In summary, the goal of this project was to incorporate changes to the current stroke 
algorithm to assure compliance with the 2015 AHA/ASA ischemic stroke guideline.   
Review of Literature 
The role of endovascular intervention in the treatment of acute ischemic stroke has been 
the topic of debate and discussion for the past 10 to 20 years.  Until recently, randomized clinical 
trials have not demonstrated efficacy of endovascular therapy.  A review of the literature was 
conducted using the key words endovascular intervention AND stroke; mechanical thrombolysis 
AND ischemic stroke; in-hospital stroke AND process maps; in-hospital onset stroke AND 
clinical practice guidelines; in-hospital stroke algorithm; stroke care pathways; code stroke; 
AHA scientific statements; ischemic stroke management.   
The Cochrane Database of Systematic Reviews was the first database explored.  Since 
Cochrane “is a collection of databases containing a variety of high-quality, independent evidence 
informing healthcare decision-making” (Craig & Smyth, 2012, p. 67), this search was conducted 
to yield evidence showing the benefit of endovascular intervention as standard treatment for 
ischemic stroke.  The database was further explored by the topic of neurology, and further 
narrowed to the topic heading of stroke.  The search included the terms of stroke treatment; 
organization of stroke services; and stroke management.  Techniques used to eliminate irrelevant 
retrievals in this database included avoiding systematic reviews or trials that did not specifically 
address recommendations for in-hospital stroke management, endovascular interventions, stroke 
patient management, care pathways or stroke response algorithms.  All references addressing 
pre-hospital or hospital presentation of stroke were eliminated from review.  
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PubMed was explored using the Clinical Queries option to secure articles that were 
evidence-based.  The initial search was similar to the search conducted in Cochrane, but also 
included the use of Boolean operators of AND and OR to refine the search linking the terms of 
tissue plasminogen activator OR endovascular intervention AND stroke.  To further refine this 
search, parenthesis were placed around both (tissue plasminogen activator OR endovascular 
intervention) to enhance the search.  The term endovascular intervention was replaced with 
mechanical thrombectomy to seek additional evidence.  Attention to the medical subject heading 
(MeSH) terms produced were monitored and used for additional database searches.   
Key words including stroke management, in-patient stroke treatment, activation system, 
code stroke, and stroke algorithm were also added to the search strategy.  The search was 
narrowed by adding the filters of age, language, and publication date.  The filters included the 
population of adults greater than the age of eighteen, the English language, and a publication 
date of the last five years. 
The literature search consistently employed the subject terms of stroke management, 
tissue plasminogen activator, endovascular intervention, stroke guidelines, and clinical pathways 
or algorithms.  Additional searches in clinical queries included the terms code stroke; stroke 
symptoms AND hospitalized patient were conducted. 
   The third database explored was CINAHL, utilizing subject terms of stroke management, 
tissue plasminogen activator, and endovascular intervention.  To refine these terms into a 
manageable search, Boolean operators were added for the search.  
 The American Association of Neuroscience Nursing (AANN) website was explored to 
assess for updated clinical practice guidelines for the care of the ischemic stroke patient.  These 
guidelines were reviewed for any recommendations specifically for the incorporation of the 
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updated AHA/ASA ischemic stroke guidelines.  The AHA/ASA website was also examined for 
updated resources related to stroke recognition, stroke statistics, educational resources available 
to improve stroke care, as well as review of guidelines and protocols developed pertaining to 
stroke care and treatment. 
 Quality clinical guidelines were reviewed by accessing websites such as the US Agency 
for Healthcare Research and Quality’s (AHRQ) National Guideline Clearinghouse (Craig & 
Smyth, 2012). Turning Research into Practice (TRIP) was also investigated to search best 
practices for implementation of new guidelines by an interdisciplinary healthcare team along 
with a more narrowed search of the newest available guidelines for stroke recognition, care and 
acute management.   
The literature search yielded multiple meta-analyses, primary studies, and two systematic 
reviews.  In an effort to secure the best available literature available, a search was conducted in 
the Cochrane, PubMed, CINAHL, and McMaster Federated ACCESSS databases using both 
keywords of endovascular intervention AND stroke; and mechanical thrombectomy AND stroke.  
The MeSH terms used for both the Cochrane database and PubMed included mechanical 
thrombolysis, stents, stroke, and thrombectomy.   
Search of the Cochrane database using keywords mechanical thrombolysis yielded one 
relevant review from the Database of Abstracts of Review and Effects. This review yielded a 
systematic review of thirteen articles evaluating the use of mechanical thrombectomy for acute 
ischemic stroke treatment (Koh, Lee, Ryu, & Kim, 2012).  In addition to the systematic review, 
the search provided one randomized control study.   
PubMed was searched using keywords mechanical thrombolysis AND stroke.  Filters of 
clinical trials, five year, and humans were applied to this search, yielding forty nine references 
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for review.  Of the forty-nine, five studies were included for further review based on the design 
and population.  The five studies reviewed included subjects experiencing an acute ischemic 
stroke, and offered both medical intervention and endovascular intervention, when eligible, as 
part of the treatment design.  Studies declined for review included those that offered either 
medical management or endovascular intervention, not evaluation for both treatment options.  A 
review of the CINAHL database failed to produce additional studies to be included in this paper.  
To assess for missed citations, the McMaster Federated ACCESSSS database was explored 
yielding two additional randomized controlled studies and two meta-reviews of literature.   
One systematic review analyzed studies (N = 13) in which patients were treated with 
mechanical thrombectomy using a retrievable stent, after intravenous tissue plasminogen 
activator (t-PA) was deemed ineligible or if it failed to open the occluded cerebral vessel (Koh, 
Lee, Ryu, & Kim, 2012).  This review identified outcomes including an 89.7% recanalization 
rate with complications of the procedure resulting in symptomatic hemorrhage of 6.8%, and an 
11.1% mortality rate.  Additionally, functional outcome improvement for this group was 47.3% 
(Koh et al., 2012).  Although this systematic review failed to show clinically significant 
improvement in the functional outcome in patients experiencing an acute ischemic stroke, this 
review did show a benefit in the use of a retrievable stent for mechanical thrombectomy over the 
only two approved devices at that time, the Mechanical Embolus Removal in Cerebral Ischemia 
(MERCI) retriever, and the Penumbra aspiration system (Koh et al., 2012).   
In 2015, the American Heart Association/American Stroke Association (AHA/ASA) 
published a focused update on the recommendations for endovascular treatment in the setting of 
acute ischemic stroke (Powers et al., 2015).  Updated guidelines were developed following the 
recently published findings from eight randomized controlled studies, five of which employed 
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the use of new generation stent retrievers for mechanical thrombolysis plus intravenous t-PA or 
administration of intravenous t-PA alone (Powers et al., 2015).   
The first three trials included in the analysis used first-generation mechanical 
embolectomy devices and failed to show a benefit of treating ischemic stroke with mechanical 
thrombolysis over intravenous t-PA administration (Powers et al., 2015).  The SYNTHESIS trial 
(Ciccone et al., 2013), enrolled patients (N=181) to receive either intravenous t-PA or 
endovascular therapy.  The primary outcome was a 90 day modified Rankin score (mRs) of 0 or 
1, indicating the patient was alive without functional disability.  The results of this trial showed a 
mRS of 0-1 in 30.4% of the endovascular group, and 34.8% in the intravenous t-PA group, with 
an odds ratio 0.71; 95% CI, 0.44-1.14; P= 0.16 (Ciccone et al., 2013).  The authors concluded 
there is no additional benefit to endovascular intervention therapy for the treatment of ischemic 
stroke over the current standard treatment of intravenous t-PA (Ciccone et al., 2013).   
Based upon the findings of five recent trials employing the use of new generation stent 
retrievals for mechanical thrombectomy, the acute ischemic stroke guidelines were updated and a 
focused 2015 guideline was published (Powers et al., 2015).  Randomized controlled trials 
(RCTs) included in the review conducted by the AMA/AHA included the Mr. Clean, ESCAPE, 
SWIFT PRIME, REVASCAT and EXTEND-IA trials.  Guidelines now recommend that patients 
who are eligible for intravenous t-pa should receive it without delay, while endovascular 
treatment is also being considered; patients should receive endovascular therapy with the use of a 
stent retrieval device only; and observing a patient’s response to intravenous t-PA before 
pursuing endovascular therapy is not recommended and should not be delayed if the patient is 
deemed eligible for this procedure (Powers et al., 2015). 
IMPLEMENTING NEW PRACTICE IN STROKE CARE 
  15  
Bush et al. (2015) conducted a meta-analysis of the five RCTs listed above.  The five 
trials enrolled patients (N=1,287) and randomly assigned subjects to either endovascular therapy 
and intravenous t-PA or intravenous t-PA alone.  Patients who were randomized to the 
endovascular intervention groups achieved a 2.22 greater odds of improved functional outcomes, 
measured using the mRS, compared to patients randomized to the intravenous t-PA control 
group.  This represented a 95% CI, 1.66 to 2.97; P<0.001 (Bush et al., 2016).  The use of 
endovascular therapy was not associated with an increase in the rate of mortality, or symptomatic 
intracerebral hemorrhage.  The meta-analysis summarized findings identifying improved 
functional outcomes for participants receiving endovascular interventions compared to 
administration of intravenous t-PA alone (Bush et al., 2016).  The positive effects of 
endovascular therapy is found in all categories including age, gender, level of neurological 
severity upon presentation, or the use of intravenous t-PA (Bush et al., 2016). 
A second meta-analysis reviewed twenty-one studies and patients (N=4,473).  Analysis 
led to the conclusion that endovascular intervention for stroke treatment improves the functional 
outcomes for stroke patients at 90 days (Tan, Wang, Ji, Tan, & Tan, 2016).  The authors 
acknowledged that although intravenous t-PA is beneficial in the treatment of stroke, there is a 
need to consider endovascular therapeutic options in the treatment of ischemic stroke (Tan et al., 
2016).  After review of the above discussed studies, the student saw a shift in support favoring 
endovascular intervention from neurological experts following the results of the most recent 
randomized controlled studies which will now be discussed (Tan et al., 2016). 
The Mr. Clean trial was a randomized controlled trial that randomly selected and enrolled 
patients (N=500) into either the intravenous t-PA control group or the intervention group which 
received endovascular intervention and intravenous t-PA group for treatment of ischemic stroke.  
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Patients in the intervention group received endovascular intervention within six hours of stroke 
symptom onset.  Stent retrieval devices, which are the newest generation devices, were used for 
all interventions (Berkhemer et al., 2015).  The study resulted with the primary outcome of 
increased functional outcome by 13.5 percentage point improvement in the intervention group; 
lack of increase in mortality, or increase in rate of intracerebral hemorrhage in the intervention 
group (Berkhemer et al., 2015).   
The ESCAPE trial, also a randomized controlled trial, equally and randomly assigned 
subjects (N=316) into either the control group (intravenous t-PA), or intervention group 
(endovascular intervention and intravenous t-PA) equally.  This trial differed from the Mr. Clean 
trial by providing endovascular intervention up to twelve hours from onset of neurological 
symptoms (Goyal et al., 2015).  This trial was stopped early due to efficacy in established 
outcomes of functional independence scores.  Outcomes for this trial were similar to those of the 
Mr. Clean trial; functional independence scores (mRs at 90 days); rate of mortality; incidence of 
intracerebral hemorrhage (Goyal et al., 2015).  This trial replicated and reinforced the findings of 
those found in the Mr. Clean trial, and further identified the value of endovascular treatment for 
patients experiencing an ischemic stroke (Goyal et al., 2015). 
The SWIFT PRIME trial was a randomized controlled trial that followed the similar 
design as both the Mr. Clean and the ESCAPE trials.  Patients were randomized within six hours 
to either the control or intervention group.  The endovascular procedure was performed using a 
stent retrieval device.  This trial was stopped early due to efficacy.  The primary outcome was a 
measure of disability at 90 days (mRS).  Secondary outcome was mortality rate, functional 
independence at 90 days, and change in neurological deficits at twenty-seven hours (Saver et al., 
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2015).  Patients in the intervention group experienced a significant improvement in the 
functional independence score resulting in the early stoppage of the trial (Saver et al., 2015). 
The REVASCAT trial was the third trial to be discontinued early as a result of 
demonstrated efficacy on the outcome of benefit and safety with the use of thrombectomy for the 
treatment of acute ischemic stroke (Jovin et al., 2015).  This was a randomized controlled trial 
assigning patients to either the control group (intravenous t-PA only) or the intervention group 
(endovascular intervention and intravenous t-PA) for treatment of ischemic stroke (Jovin et al., 
2015).  Study findings included a functional independence increase of 15.5 percentage points in 
the endovascular group.  This demonstrated that 6.5 patients would need to be treated to prevent 
one death or significant disability.  As a result of these early positive findings as well as similar 
results from concurrent studies, enrollments were terminated to avoid ethical concerns related to 
assigning subjects to the control group known to have inferior outcomes (Jovin et al., 2015). 
The EXTEND-IA is a randomized controlled study designed with the control group 
(intravenous t-PA) and intervention group (endovascular intervention and intravenous t-PA).  
The endovascular intervention was initiated within six hours of stroke symptom recognition 
(Campbell et al., 2015).  The trial enrollment was stopped upon release of the Mr. Clean study 
which reported significant improvement in functional outcomes in the intervention group 
receiving endovascular intervention.  This enrollment was terminated to avoid the ethical 
dilemma associated with enrollment of patients into the control group which could result in 
inferior functional independence or other complications (Campbell et al., 2015). 
The five trials have multiple similarities contributing to the development of a robust body 
of evidence highlighting the benefits of endovascular intervention as an early treatment option 
for patients who are experiencing an ischemic stroke.  The trials were designed to incorporate the 
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use of the newest generation of stent retrieval devices disregarding the earlier devices from 
previous studies that may have impacted outcomes.  As well as demonstrating the improvements 
made to the retrieval devices used to perform these procedures, the studies incorporated the use 
of advanced imaging to refine the selection criteria to identify appropriate candidates for 
endovascular intervention (Berkheimer et al., 2015; Campbell et al., 2015; Goyal et al., 2015; 
Jovin et al., 2015; Saver et al., 2015).   
The studies differed in the eligibility criteria when assessing time from symptom onset to 
intervention.  Mr. Clean, SWIFT PRIME, used the timeline of six hours from stroke symptom 
onset, REVASCAT used the timeline of eight hours, ESCAPE used twelve hours for the 
timeline, and EXTEND-IA did not use time as a variable, but used size of completed infarction 
based upon imaging results for eligibility criteria (Berkheimer et al., 2015; Campbell et al., 2015; 
Goyal et al., 2015; Jovin et al., 2015; Saver et al., 2015).   
The use of computed tomography perfusion scans (CT perfusion) has become 
increasingly important in patient selection for endovascular intervention and has contributed to 
improving patient safety in the performance of these procedures.  Increasing use of CT perfusion 
has reduced the risks associated with these procedures by improving the patient selection process 
(Goyal et al., 2015; Jovin et al., 2015; Saver et al., 2015). 
The five trials included subjects from diverse backgrounds and from multiple countries, 
ages, ethnic backgrounds, and medical histories.  Although a diverse group, designs for the 
studies remained similar with randomization to the control or intervention group, use of 
improved stent retrieval devices, administration of intravenous t-PA to eligible patients, and use 
of CT perfusion to promote safety and efficacy throughout the trials.  The treatment effect of 
endovascular interventions demonstrated a need to offer this treatment for eligible patients 
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experiencing an acute ischemic stroke.  The primary outcome demonstrated a positive treatment 
effect when endovascular intervention is performed and included an analysis of the number 
needed to treat to improve the outcomes of one patient.   
Primary outcomes across the five trials were similar, all evaluating the level of functional 
independence at 90 days (mRs), rate of mortality, and complications of symptomatic 
intracerebral hemorrhage (Berkheimer et al., 2015; Campbell et al., 2015; Goyal et al., 2015; 
Jovin et al., 2015; Saver et al., 2015).  In all studies, statistical significance was found in the 
improvement of functional independence for those in the intervention groups; there was an 
absence of statistical significance in increase of mortality rates or intracerebral hemorrhages in 
the intervention group (Berkheimer et al., 2015; Campbell et al., 2015; Goyal et al., 2015; Jovin 
et al., 2015; Saver et al., 2015). 
Four of the five studies reviewed were terminated early due to efficacy reached and it 
was determined to be ethically unacceptable to continue enrolling patients into the control arm of 
the trial and deny the offer of endovascular intervention if they met the eligibility criteria 
(Campbell et al., 2015; Goyal et al., 2015; Jovin et al., 2015; Saver et al., 2015).  Although the 
studies were stopped prior to the complete enrollment of the predetermined number of 
participants, the sample size and the data generated from the studies were powerful and 
reinforced the findings of the pivotal Mr. Clean study.  
The studies effectively addressed the questions surrounding the role of endovascular 
intervention in the treatment of acute stroke.  The five randomized, controlled studies had similar 
designs including the control and intervention group assignments, use of imaging in the analysis, 
and statistical analysis of both primary and secondary outcomes.   
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Based upon the findings of the randomized controlled studies, systematic review, and 
meta-analysis, it was reasonable to consider a review of the current stroke response algorithms to 
assure the incorporation of this new evidence.  To accomplish this, an evaluation of current 
processes, algorithms, as well as the development of treatment criteria may aid in rapidly 
identifying patients who would be eligible to receive this time sensitive treatment.  The 2015 
AHA/ASA update of the acute ischemic stroke guidelines resulted, in part, from a review of 
recent randomized clinical trials, including those discussed in this literature review within this 
paper (Powers et al., 2015). 
Theoretical Framework 
 To implement this program improvement project, an evidence-based practice (EBP) 
model was utilized to assist with the steps of assessment, implementation, and evaluation of the 
implementation process.  Evidence-based practice models assist the leader to avoid “failure in 
completion of implementation of projects, help to facilitate establishment and evaluation of 
outcomes, and improvement in utilization of available resources” (Schaffer, Sandau, & Diedrick, 
2012, p. 1199).    
 The doctoral student/project coordinator referred to the framework of the Advancing 
Research and Clinical practice through close Collaboration (ARCC) model.  This project 
involved a practice change at a system level, making this model an appropriate framework to 
guide, as it can be utilized to help health care systems employ and sustain evidence-based 
practice change.  Implementation of this practice change proved to be a complicated process 
occurring within a healthcare system wrought with complexity.  Although evidence to support 
endovascular intervention for the treatment of ischemic stroke has been well established, 
implementing this practice change throughout the hospital setting, evaluating the implementation 
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process, and creating a sustainable change throughout the hospital  benefited from employing   
concepts identified in the ARCC model. 
 The ARCC Model was developed in 1999 at a major medical center for the purpose of 
improving patient outcomes and quality measures through translation of evidence into clinical 
practice (Melnyk, 2012).  The ARCC model is structured to focus on “organizational use, 
assessing both organizational strengths and barriers to change; identifies EBP mentors; assesses 
organizational culture; implements evidence; evaluates outcomes” (Schaffer et al., 2012, p. 
1201).  It is based on the assumptions that “there are both barriers and champions of EBP within 
the health care system; that barriers must be removed, and champions must be mentored; 
clinicians must believe in the value of the EBP change that is to be implemented; mentors for 
EBP change must be developed and are necessary for the health care system to sustain the 
proposed change” (Melnyk, 2012, p. 132).   
Methods 
 To implement this project, the project coordinator met with key stakeholders including 
the chair of the neurology department, the stroke program manager, neurologists, advanced 
practice nurses, nursing educators from the neuroscience department, and the vice-president of 
neuroscience, to translate the 2015 AHA/ASA stroke guideline into a revised in-house stroke 
algorithm that is tailored to the hospital system. The DNP student/project coordinator, in 
collaboration with the stroke manager, presented the suggested changes resulting from this 
collaboration to the  stroke committee, which is chaired by the Chief of Neurology.  Following 
acceptance of the revised algorithm, the Chair of Neurology presented these changes to the 
Pharmacy and Therapeutics (P&T) committee, and then to the Medical executive committee.   
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 Once changes to the algorithm progressed through the hospital’s committee approval 
structure, the DNP student/project coordinator led a multidisciplinary team to begin the steps for 
implementation of the program improvement project.  To assure successful implementation of 
this project, the project coordinator engaged the multidisciplinary team in a review of the current 
stroke algorithm, presented the suggested changes to the algorithm, and performed a  Strengths, 
Weaknesses, Opportunities and Threats (SWOT) analysis prior to development of the 
implementation plan (Figure 1).  Evaluation of the program’s success is conducted by the stroke 
committee, led by the chair of neurology and the stroke manager at the monthly stroke working 
group meeting. 
Project Design 
 A SWOT analysis specific to updating the algorithm and revising associated processes 
and care practices was conducted with key team members of the stroke and neurology 
department by the DNP student/project coordinator.  This was a helpful step early in the process 
as it helped to inform project planning processes.  A SWOT analysis allows the team to help 
focus on areas where it is strongest and allows the team to identify where key opportunities exist 
(Pearce, 2007).   
 Following completion of the SWOT analysis, the DNP student developed and maintained 
a Gantt chart to identify and assign tasks with timelines for expected completion.  This tool 
assisted the DNP student/project coordinator with delegation of tasks and clarification of roles 
for all team members.  Utilization of this tool aided in the assessment and identification of 
barriers to the project’s successful implementation.  The Gantt chart was initially developed 
close to 100 years ago, and although revisions have occurred, it has proven to be effective and 
resilient when applied to overall project management.  This chart is known as a valuable tool 
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when used to navigate complicated projects due to the focus on tasks and timing (Geraldi & 
Lechter, 2012).   
 The Gantt chart was utilized to highlight the start and completion dates of the tasks, as 
well as to provide the team with a visual depiction of the relationships between the tasks 
assigned.  The chart was also used to show the project’s status of proposed meetings throughout 
the project timeline.  Tasks with months of completion are represented on the chart. (Figure 3).  
 Initial planning meetings included the clinical leadership throughout the hospital system 
to obtain a broad assessment of all potential barriers as well as potential champions of the 
project.  Once the Gantt chart was developed, the process of implementation was initiated, with 
the DNP student/project coordinator monitoring progress. Revisions occurred as needed based 
upon monitoring of progress, reporting of any unforeseen obstacles, re-evaluation of process, and 
receipt of ongoing feed-back to clinical and administrative leadership.    
Setting 
The setting for this project was the main campus of hospital, located at Philadelphia, 
Pennsylvania.  The hospital a 937 bed tertiary acute care facility with five locations in the greater 
Philadelphia area that provides care to a diverse population and wide range of clinical specialties 
including trauma, neurosurgery, orthopedic, and oncology to name a few.  This project included 
the main campus, as well as the specialty hospital for neuroscience.   This facility is a Joint 
Commission Certified Comprehensive Stroke Center, and is a regionally recognized 
neuroscience center that provides primary stroke care services to over 28 community hospitals in 
the surrounding communities.  It is ranked 24
th
 in the country in Neurology and Neurosurgery 
with a score of 65.6% (U.S. News and World Report, 2015). 
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Evaluation   
Completion of the project was based upon revision of the in-house stroke algorithm, 
approval of the algorithm, and hospital wide implementation of new algorithm.  To perform 
ongoing evaluation, the stroke manager reviews all in-house stroke cases at monthly stroke 
working group meetings to assess the effectiveness of the current process. 
Revision of the current stroke algorithm was initially met with resistance from the 
hospital’s rapid response team (RRT).  This was a critical issue requiring the assistance from the 
chair of neurology to achieve resolution.  The leadership of the RRT initially opposed the 
involvement of this team for the activation of a stroke alert notification citing a strain on 
available resources this process demands.  This allocation of resources was discussed by the 
neuroscience clinical leadership in collaboration with the administration of the hospital.  It was 
decided the RRT would respond to stroke alert activation in non-critical areas only and remain 
with the patient and the neurologist until disposition.  In the event a stroke alert occurred in a 
critical care area, the critical care staff nurse would remain with the patient, along with the 
neurologist, throughout the initiation of the stroke alert until patient disposition.   
Due to the variation in practice between the critical care and non-critical care units, the 
Advanced Practice Nurse (APN) group was provided with a focused power-point education 
highlighting the revision of the stroke algorithm specific to the earlier consideration of 
endovascular intervention.  Additionally, education was developed and provided to address the 
unit specific patient emergency escalation process, as well as a review of the acute signs and 
symptoms of ischemic stroke.  Educational implementation included the offer of both the stroke 
manager and the DNP student/project coordinator to meet with the staff in the monthly shared 
governance meetings to provide the education.  The APN group preferred to accept the 
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responsibility to provide the staff with the education focusing on these three components, and 
will be involved in ongoing evaluation of stroke treatment outcomes on their units at ongoing 
APN meetings.  It was further suggested to enhance the communication by empowering the 
stroke manager to provide ongoing updates on case studies and summaries of patient outcomes to 
the individual units.  
Revision to the algorithm was also met with feedback from the neuroscience educational 
department.  They believed the algorithm should have been terminated with the decision to 
administer IV tPA, perform endovascular intervention, or perform both.  The group felt the 
additional steps of the algorithm were redundant and unnecessary.  The stroke committee 
reviewed the algorithm and decided that although this may appear to be redundant in the 
specialty hospital for neuroscience, it was a necessary step in the algorithm for a non-
neurological, medical-surgical unit. The chair of neurology decided to keep the algorithm as 
presented, and continue with the proposed education.  
 Although the opportunity to test this algorithm was not possible for this project, processes 
were developed to provide ongoing analysis of outcomes for all in-house stroke alerts.  The 
stroke working group, co-chaired by the chief of neurology and the stroke manager, added a 
standing agenda item for a monthly review of all in-house strokes.  Metrics that will be evaluated 
include the patient’s last known well time to activation of the stroke alert system, time from last 
known well to decision to administer IV tPa if appropriate, and time to last known well to arrival 
at endovascular unit for intervention as appropriate.  This is a significant shift in practice as it is 
the first time these outcomes will be traced for an in-house stroke patient.  Additional outcomes 
that will be captured are the rate of patients who are eligible and receive endovascular 
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intervention for stroke, and the time from recognition of stroke to vessel access.  This data will 
be collected and analyzed by the neurology department and reported to the stroke working group. 
 With the ongoing monitoring of the above stated metrics, it is possible to continue the 
development of additional process improvement practices and procedures that will continue to 
improve the care offered to the in-house stroke patient population, with the goal to positively 
impact the long term outcomes of this vulnerable population. 
Human Subjects Protection 
 Application for initial Investigational Review Board (IRB) approval of this project from 
the health system was followed by subsequent review by Drexel University’s IRB. Both IRBs 
determined that the project satisfied requirements as a quality improvement project was granted 
exempt status. 
Timeline 
The timeline for the entire project was approximately ten weeks and commenced upon 
approval of the project coordinator’s committee chair as well as IRB approval (Table 1).  
Strengths and Limitations  
The success of this program improvement project was determined by the acceptance of the 
in-house stroke algorithm by the multidisciplinary stroke committee and the implementation of 
the project throughout the hospital.  A strength of this project was the translation and application 
of new evidence into the clinical practice setting.  The goal of a revised stroke algorithm was to 
increase awareness of the revised stroke guideline and to offer an increased opportunity for 
hospitalized patients to be evaluated for endovascular intervention in the initial treatment phase 
of an acute ischemic stroke.  A second  strength was the development of a new process to review 
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all in-hospital strokes at the monthly stroke working group meeting.  The goal of this review is to 
identify process improvement opportunities in an effort to improve stroke care delivery.    
A limitation of this project was that although the revised algorithm supports the latest 
evidence in stroke treatment, the possibility of failure to recognize the patient’s stroke symptoms 
in a timely manner still exists. This potential failure to recognize an acute stroke would impact 
the rate of endovascular intervention offered to patients experiencing an ischemic stroke.  
Although the revised algorithm also addresses the signs and symptoms of stroke, recognition of 
subtle stroke symptoms rely upon the clinical staff’s recognition of the patient’s change in 
neurological status. 
A second potential limitation of the project may be the individual or unit based 
nonadherence to the revised algorithm.  Although education was provided at the unit level by the 
APN group highlighting the need to escalate an emergency response with a neurological change, 
if the algorithm was not followed, neurology experts would not be called to the patient’s bedside.  
This failure to activate the stroke alert algorithm would result in a delay in stroke care for the 
patient experiencing an acute ischemic stroke.  
Significance and Implications 
 There is potential for future areas of study with this project both within this health system 
as well as within the surrounding Neuroscience Network.  With this revision of the algorithm, 
patients are being offered the opportunity to receive the best options for acute ischemic stroke 
care, and it will be important to study the impact of this practice change on overall patient 
outcomes, particularly the modified Rankin scores and mortality rates.  Future studies may 
include an assessment of stroke response time, and adherence to the updated stroke algorithm, 
rates of endovascular intervention, and functional outcomes of patients who are treated with 
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endovascular intervention comparing these data to the same outcomes prior to revision of the 
algorithm.   
 Implications of this project include the potential to replicate this program improvement 
process with future initiatives within the health system as new evidence is presented.  
Opportunities were presented resulting with the establishment of a process that engaged a 
multidisciplinary team focused on the revision of stroke algorithm to improve stroke care 
throughout the hospital.  This process may be transferable to multiple healthcare initiatives 
throughout the healthcare system, potentially impacting care delivery and patient outcomes.  This 
project was pivotal in the identification of committee structure, process, and navigation 
techniques to spearhead the practice change through a complex structure. 
 Finally, future implications include the potential translation of this practice change 
throughout the hospital system’s neuroscience network of primary stroke centers.  Clinical 
leaders of primary stroke centers can utilize this algorithm as an opportunity to identify early 
triggers or stroke characteristics to escalate the transfer of a patient to a comprehensive stroke 
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Tables 
Table 1.  Timeline for Project Improvement Project 
Task Date 
1. Assessment of organizational culture 
and readiness for EBP implementation 
1. October 2016 
2. Conduct a SWOT analysis with 
multidisciplinary neuroscience team 
members 
2.   October, November 2016 
3. Meet with key neuroscience 
interdisciplinary team to perform 
revision to current in-house stroke 
algorithm 
3.   October 2016 
2. Develop Gant Chart for Project 
development and implementation  
4. September 2016 
3. Meet with Stroke Committee to 
Present Revised In-House Stroke 
Algorithm for Approval 
5. November 2016 
6. Review revised algorithm with Rapid 
Response Team/Advanced Practice 
Team/Neurology Medical 
Committee/INR Staff/ Stat Team 
4.   November 2016 
7. Meet with APN group to discuss 
Implementation of Educational Plan at 
Unit level.  
5.   November, December 2016 
8. Development Educational 
Presentation for the hospital clinical 
staff 
6.  November, December 2016 
9. Stroke Manager will review all in-
house stroke alert cases at monthly 
Stroke Committee Meetings 
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Table 2. 
Table of Evidence 
Author/ 
Date 







Purpose:  Discover if  
non-adherence to stroke 
core measures result in 
delay in treatment for the 
in-patient stroke 
population in 
comparison to the 
patient community onset 
stroke 
 
Design:  Cohort Study.  
Retrospective review of 
database 
Inclusion Criteria:  
Hospitals who participate in 
the Get With The 
Guidelines(GWTG) Stroke 
quality measure database 
and reported at least 1 
stroke from both groups 
studied  
Exclusion Criteria:  Age 




The consortium of 35 
statewide hospitals- years 
study included (2005-
2009).  In-hospital stroke 
(n=116); out-of-hospital 
strokes (n 4,946) were 
compared. Cohort mean age 
71.5, 46% male, 77.8% 
were white.   
Outcome Concept: 
Primary outcome is 
adherence to 9 or 10 
GWTG quality measures.  
Secondary Outcome include 
adherence to GWTG 
measures and time from 
symptom recognition by 
staff to brain imaging 
Measures/Instrument:  
Stroke Core Measures 
reported to national 
database Get with the 
Guidelines. Analysis via 
SAS statistical software. 
Interventions: Compare 
whether patients who have 
a stroke while hospitalized 
receive the same standard 
of care as those patients 
who arrive to the hospital 
from the community 
diagnosed with Stroke 
Results/Findings: 
High variability in 
the percentage of 
in-hospital strokes 
reported suggests 








more likely to 
have CAD 
(p=0.02), have a 
higher NIHSS 
(p=0.01), had a 
longer time from 
symptom 
recognition to 
brain imaging.  




and assessment of 
rehabilitation 
needs was better 
for the in-hospital 




rates for eligible 
patients were 




had a higher rate 
of 
contraindications 











have time to 
brain imaging 






















symptoms.  If 
only a 
percentage of the 









possibly bias by 
only reporting 
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treatment, with or 
without intraarterial t-PA 
is more effective than 
treatment with IV t-PA 
alone 
Design:  Randomized 
controlled study. 
Inclusion Criteria: 
Patients aged 18 to 80 with 
acute ischemic stroke; 
clearly defined time of 
symptom onset- 4.5 hours 
for IV t-PA and up to 6 




clinical trial with a blinded 
end point. Patients were 
randomized into the control 
group (n=181) of receiving 
IV t-PA only and the 
intervention group received 
endovascular therapy only 
(n=181). 
Outcome Concept: 
Primary outcome was 
survival with a functional 
independence measure as a 
modified Rankin score of 0 
to 2 at three months.   
Measures/Instrument:   
The study was designed to 
determine whether there 
was an absolute difference 
of 15 percentage points 
between the proportions of 
patients with a mRS 
between the control and 
intervention groups.  
Interventions: Control 
group was offered medical 
intervention (IV t-PA) only 
for treatment of ischemic 
stroke; intervention group 









outcome at 3 
months between 
the two groups 
was not 
statistically 
significant.  Odds 
ratio adjusted for 
age sex, stroke 
severity, and atrial 
fibrillation, 0.71: 
95% CI, 0.44 to 
1.14: P=0.16.  
Intracranial 
hemorrhage was 
equal among the 










the ability to 
verify the patient 








during this trial, 
which may have 
provided greater 
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Powers et 
al. (2015) 
Provide a focused update 
on recommendations for 
the role of endovascular 
intervention in the 
treatment of acute 
ischemic stroke 
Design:  Review of 8 
randomized, clinical trials 
of endovascular treatment 
for ischemic stroke 
published from 2013 until 
2015 
Recommendation 
to publish a 





include the role of 
endovascular 
treatment for 









therapy with a 
stent retriever if 
















treatment plus IV t-PA 
would be more effective 
than IV t-PA alone for 
patient with a proximal 





Design:  Randomized 
controlled study 
Inclusion Criteria:  
Patients aged 18 or older 
with a proximal arterial 
occlusion in the anterior 
cerebral circulation; 
confirmed by imaging; 
treatable within 6 hours 
after stroke symptom onset.  
Characteristics/Setting:  
The study enrolled 500 
patients from 16 medical 
centers in the Netherlands.  
Mean age was 65; 233 
patients were assigned to 
the intervention group (IV 
t-PA + intervention)/267 
assigned to the control 
group (IV t-PA only).  
Demographics similar for 
both groups. NIHSS 17 for 
Intervention group/18 for 
Control group.  Risk factors 
for stroke and aspects 
scores of pre-randomization 
treatment were evenly 
distributed between the two 
treatment groups     
Outcome Concept: 
Primary outcome was rate 
of functional independence 
(modified Rankin score 0 to 
2).  Secondary outcome was 







needed sample of 
500 patients to 
yield a power of 
82% at a 
significance level 
of 0.05 to achieve 
an increase of 10 
percentage points 
of a modified 
Rankin score of 0 
to 3 in the 
intervention group 





was 13.5 with a 
95% CI 5.9 to 
21.2. 














initiates within 6 





with 34 more 
assigned to the 
control group; 
the rate of 
reperfusion was 
low compared to 
other similar 
studies; 9%  of 
patients in the 
intervention 
group had an 
embolization of 
a second vessel 
due to additional 
clot formation; a 
lower proportion 
of patients in the 
control group 
  Level I 
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The study was designed to 
determine whether there 
was an absolute difference 
of 15 percentage points 
between the proportions of 
patients with a mRS 
between the control and 
intervention groups.  
Interventions: Control 
group was offered medical 
intervention (IV t-PA) only 
for treatment of ischemic 
stroke; intervention group 
was offered endovascular 
intervention only 
had a mRS of 0-
2 at 90 days due 







aware of what 
group they were 
in which may 
have influenced 
their opinions on 


















Purpose: The purpose 
of this trial tested 
whether more advanced 
imaging, recently 
developed stent retrieval 





Design:  Randomized 
Controlled study. 
Inclusion Criteria:  Adult 
patients age 18 or older 
experiencing an ischemic 
stroke who were eligible to 
receive intravenous 
alteplase within 4.5 hours; 
had an anterior circulation 
stroke; occlusion of the 
internal carotid artery; or 
the first or second segment 
of the middle cerebral 
artery; had salvageable 
brain tissue demonstrated 
by CT perfusion. 
Characteristics/Setting 
Seventy patients underwent 
randomization (n=35 in 
control group, n=35 in the 
intervention group.  Ten 
study centers (Australia and 
New Zealand).  Average 
age 68-70; equal number of 
male/female between 
groups; NIHSS in 
intervention group was 17 
vs. 13 in the control group. 
Outcome Concept: 
Primary outcome was 
reperfusion of occluded 
vessel, and early neurologic 
improvement, identified as 
an 8 point improvement of 





greater in the 
intervention group 
vs. the control 
group (median, 
100% vs. 37%, 




greater in the 
intervention group 
vs. the control 
group (71% vs 
40%, P= 0.01).  
Endovascular 
group had greater 
early neurological 
















strokes in a 
proximal vessel 
with salvageable 








the use of stent 
retrieval devices 
and IV t-PA, 
than those that 
receive IV t-PA 
alone 
Limitations: Do 
to the small 








the trial may 
result in the 
  Level I 
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the NIHSS, or a score of 0-
1 at 3 days post event.  
Secondary outcomes 
included the NIHSS at 90 
days; death for any reason; 
and symptomatic 
intracranial hemorrhage.  
Measures/Instrument: The 
trial was stopped early due 
to efficacy at 70 patients.  
The percentage of ischemic 
territory that was reperfused 
was greater in the 
intervention group vs the 
control group (median, 
100% vs. 37%, P=0.001).  
The improvement in 
functional outcome was 
greater in the intervention 
group vs. the control group 
(71% vs 40%, P= 0.01). 
Interventions: 
Endovascular intervention 
with stent retrieval devices 
+ IV t-PA in the 
intervention group vs. IV t-




















90 days) odds 
ratio, 2.0; 95% CI, 
1.2 to 3.8; 
P=0.006 
Findings: The 
study was stopped 
early due to 
efficacy.  Re-






need to offer this 


















For patients with an 
anterior proximal 
cerebral occlusion 
stroke, up to 60 to 80 
percent of these patients 
may die within 90 days 
Design: prospective, 
randomized, open-label, 
controlled trial with blinded 
outcome evaluation; 
PROBE design.  
Randomization was 
Results:  The 90 
day mRS in the 
intervention group 
was 2, and 4 in 





failed to keep a 
log of how many 
patients were 
Level I 
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addition to intravenous t-
PA administration may 
improve these outcomes. 
 
achieved through an 
internet-based procedure 
aimed to achieve balance in 
the groups related to age, 
sex, baseline neurological 
deficit, location of cerebral 
occlusion, and baseline 
Alberta Stroke Program 
Early Computed 
Tomography Score 
(ASPECTS).   
Inclusion Criteria: Adults 
with no upper-age limit; 
disabling stroke who were 
functioning independently 
prior to this event; 
enrollment up to 12 hours 
after onset of stroke 
symptoms.  Patients with a 
large core infarct, or poor 
collateral circulation as 
demonstrated by CT 
angiography were excluded. 
Characteristic/Setting:  
Worldwide trial/22 centers 
with 316 participants.  Of 
the 312, the intervention 
group (n=165), control 
group (n=150).   
Demographics of 
intervention/control groups 
were similar.  Risk factors 
for stroke and aspects 
scores of pre-randomization 
treatment were evenly 
distributed between the two 
treatment groups. 
Outcome Concept:  The 
primary outcome measured 
was the 90 day mRS of 0-6 
 occurred in 3.6% 
intervention vs. 2.7% 










were the preferred device 
used for procedures/IV t-
PA if met criteria.  The 
intervention vs. 
29.3% control). 
This is P<0.001.   
 The primary 
outcome 
measured was the 
modified Rankin 
score at 90 days 
resulted with a 
common odds 
ratio, 2.6; 95% 
confidence 








groups.  P=0.04. 
Symptomatic ICH 






inclusion in the 
trial.  A high 
percentage of the 
endovascular 
group was 










not exist in all 
facilities, the 
generalizability 
of these results 
may be limited 
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control group received the 
current standard medical 














The authors questioned 
whether treatment with 
mechanical 
thrombectomy with the 
use of a stent retriever in 
addition to intravenous t-
PA improve cerebral 
reperfusion and  improve 
long-term functional 





Inclusion Criteria: All 
patients included had an 
acute ischemic stroke with 
moderate to severe 
neurologic deficits; had a 
proximal vessel occlusion 
verified by imaging; 
received IV t-PA; and were 
eligible to undergo 
endovascular intervention 
within 6 hours of symptom 
onset 
Characteristics/Setting:  
Participants were randomly 
assigned to either the 
intervention group (IV t-PA 
plus stent retriever group) 
or the control group (IV t-
PA group only) via an 
interactive web based 
system.  Patients were 
assigned in equal number 
(1:1) to one of two 
treatment arms: 1) IV t-PA 
and Solitaire FR or 2) IV t-
PA only. 
The groups were similar in 
age, sex, race, NIHSS, 
admin of iv t-PA at outside 
hospital, median time from 
symptom onset to iv t-PA, 
and ASPECT value.  The 
number of treatments and 
controls will be balanced 
within investigational sites 
and by baseline NIHSS 
severity (<= 17 versus >17), 
age, and occlusion location 
within site. 
Outcome Concept: 
Primary outcome measured 
was mean mRS at 90 days.  
Secondary outcome was the 
mortality rate at 90 days, 
Results:  The 
primary outcome 
was a shift in the 
distribution of 
global disability 
scores on the 
modified Rankin 
scale at 90 days.   
Result P<0.001.  




P<0.01to stop the 
study (Saver et 
al., 2015). 
The number 
needed to treat for 
one additional 
patient to have 
less disability was 
2.6. 
The secondary 
outcome looked at 




group at 90 days.  
The intervention 
group had a 
difference of 25 
percentage points 
with a 95% CI, 11 
to 38; risk ratio of 
1.70 with a 95% 
CI, 1.23 to 2.33; 
P<0.001. 
The number 
needed to treat to 
obtain one more 




score of 0-2) was 
Limitations: 
Generalizability 
may be limited 
due to the 
homogeneous 
patient 











process.  The 
centers involved 
in the trial were 















IV t-Pa and 
endovascular 
intervention with 
a stent retrieval 
device within 6 
hours of stroke 
symptom onset 
Level I 
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and the change in the 
NIHSS at 27 hours 
following randomization 
Measure/Instrument: 
Disability rate at 90 days as 
measured by the mRs; inter-
group differences in 90 day 
mortality; inter-group 




with stent retrieval devices 
within 6 hours of symptom 
onset + IV t-PA in the 
intervention group vs. IV t-
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Figures 
Strengths 
 Identifies members of its leadership team 
 Neuro Resident coverage 24/7 
 Endovascular team on call  24/7 
 Capable to perform neurovascular 
procedures advocated for with algorithm 
change 24/7 
 Current Stroke Program Manager 
 Dedicated Neuroscience Hospital 
 Dedicated Rapid Response Team 
 Auto-Acceptance for all Stroke patients 
 APNs coverage in majority of clinical areas 
 Neuroscience Education team 
 Clinical Administration for Neuroscience  
 Evidence of specific stroke performance 
measurement and review by the stroke team 
 System-wide clinical sub-committee team 
meetings with review of performance 
measure 
Weakness 
 Rapid Response Team administration does 
not support teams involvement in Acute 
Ischemic Stroke algorithm 
 Neurology Resident responds to Stroke 
Alerts without support from other clinical 
disciplines 
 Current fragmentation of program 
leadership and resources impedes ongoing 
strategic planning and implementation 
 Variation in activation of patient emergency 
response from unit to unit 
 Lack of formalized structure to evaluate 
stroke response time and patient outcomes 
 Reporting structure follows discipline, not 
service line 
 Metrics for time sensitive advanced stroke 
intervention not captured 
 Lack of formalized PDSA process for Stroke 
metrics 
 Current Stroke Working group meeting 
without consistent medical leadership 
Opportunities 
 
 Introduce the updated algorithm to stroke 
centers in the hospital’s Neuroscience 
network 
 Collaborate with hospital’sNeuroscience 
coordinators to partner with facilities within 
the neuroscience network to implement the 
newest guidelines into practice 
 Engage Stat in the process improvement 
efforts to decrease time to treatment for 
Acute Ischemic stroke from the Main 
building to neuro specialty hospital 
 Increase communication from the hospital’s 
transfer center to the INR suite 
 Increase professional collaboration through 
a multidisciplinary effort to decrease the 
time from recognition of stroke symptoms to 




 Use of Jeff Stat for surrounding hospitals 
may impact the availability of immediate 
transport 
 Fragmented Med-Surg Stroke Alert 
activation system 
 Lack of involvement from RRT during 
immediate stroke response may delay care 
 Limited resources at bedside at onset of  
stroke 
 Lack of streamlined transfer from Main 
Building to INR at Neuroscience building   
 Multiple transfers from outside facilities to 
INR suite may delay patient care/patient 







Figure 1. SWOT Analysis 
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IN-HOUSE ACUTE STROKE ALGORITHM 
HOSPITALIST 
-Rapid assessment of 
NIHSS 




-Activate Stroke Alert 
 




CALL STROKE ALERT 
Gibbon: 5-6074 
JHN: 3-9999 
Advise: “Stroke Alert” & “Room Number” 
EITHER Stroke tPA < 4.5 hrs 
OR Stroke Endovasc: LKW=4.5-12 hours 
 
Stroke Symptoms 
F- FACE DROOPING: Does one side of the face droop or is it numb? 
A- ARM WEAKNESS: Is one arm weak or numb? 
S- SPEECH DIFFICULTY: Is Speech slurred: Is the person unable to speak or hard to understand? 
T- TIME TO CALL RAPID RESPONSE TEAM: If someone shows any of these symptoms, check 
the time so you’ll know when the first symptoms appeared. 
PRIMARY RN:  Establish time of onset of symptoms or Last Known Well-time 
(LKW).  Obtain blood glucose. 
STAT NON-CONTRAST CT SCAN HEAD 
Confirm IV/Line access 
CBC, PLT Count, BMP, PT/PTT/EKG 
Make patient STRICT NPO (including PO medications) 
 







Criteria for IV tPA 
Initiate Acute Ischemic Stroke IV tPA 
Algorithm 









Gibbon: (877) 656-5402 
JHN: (877) 656-5403 
Initiate Hemorrhagic 
Stroke Algorithm 
(ICH or SAH) 
Figure 2. Current In-House Acute Stroke Algorithm 
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Al : Consider t 























If patient shows any of the above symptoms Activate 
Rapid Response Team/Stroke Alert 
(THE ACTIVATION PROCESS IS UNIT SPECIFIC) 
**R/O Stroke Mimics** EMERGENCY NUMBERS 




Stroke Symptoms (Acute and Sudden Onset) 
B- Balance: dizzy/coordination/vertigo 
E- Eye: Visual changes/diplopia/loss of vision 
F- FACE DROOPING: Does one side of the face droop or is it numb? 
A-ARM WEAKNESS: Is one arm weak or numb? 
S- SPEECH DIFFICULTY: Is Speech slurred: Is the person unable to speak or hard to understand? 
T- TIME TO CALL RAPID RESPONSE TEAM/Stroke Alert: If someone shows any of these symptoms, check the time so you’ll know 
when the first symptoms appeared. 
Neurology Resident/Primary RN Respond 
STAT NON-CONTRAST CT SCAN HEAD 
Confirm IV/Line access (Secure line above the wrist) 
CBC, PLT Count, BMP, PT/PTT/EKG 
Make patient STRICT NPO (including PO medications) 
 
CT Scan without Evidence of Hemorrhage 
Consider IV tPA and/or Endovascular Intervention 
Patient meets Criteria for 
Endovascular Intervention 
Only 
Patient meets Criteria for IV 



































Gibbon: (215) 554-4172 
JHN: (215) 554-4605 
Initiate Hemorrhagic 
Stroke Algorithm 
(ICH or SAH) 
Patient meets Criteria for 




























Figure 3. Revised In-House Acute Stroke Algorithm 
Stroke Alert Called 
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 Sept 2016 VP of Clinical Services  
 














EG  Completed October 
2016 
Collaboration with the 
Stroke Committee 
 and Chair of hospital 
Stroke Program 
 to propose revisions to 
current 
 In-house Acute Ischemic 
Stroke  
























Partnered with the  Stroke 
Manager/Neurologist 
lead/Neuro APN/Neuro 
Education team to develop 
a SWOT analysis 










CP Completed November 
2016 
Physician champion chairs 
meeting and will present 
changes to algorithm to the 
hospital Stroke Committee 
meeting for approval 
 


















Presented changes to the 
In-House Acute Ischemic 
Stroke Algorithm to Key 
Stakeholders 
 Neuro Working 
Group 
 Rapid Response 
Team 
 Hospital APN 
Committee 
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 Stat- Presented to 
Supervisor of 
Dept 










CP Completed November 
2016 
Physician  presented 
revised algorithm to 
approval committees 
 Presented and 
approved by P&T 
committee 
 Presented and 
approved by MEC 










CP Completed  Overview of algorithm 
revisions presented to 
Neurology Medicine 
Department 


















Met with the APN group to 
discuss overview of 
algorithm revisions 
 Provided 
education to the 
APN group 
 Provided power-
point slides to 
guide APN group 
for ongoing 
education to staff 
at unit level 
 






Ongoing RD/CP Completed  Standing agenda item 
added to Stroke committee 
monthly meeting 
Review of all in-house 
stroke alerts  
 
 
Figure 4: Gantt chart   
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